Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Becton Dickinson to acquire Bard for $23.5bn

Executive Summary

Becton Dickinson & Co. agreed to acquire CR Bard Inc. (medtech focused on vascular, urology, and oncology) for $317 per common share (27% premium), or $23.5bn in cash and stock including net debt.
Deal Industry
  • Medical Devices
    • Diagnostic Imaging Equipment & Supplies
      • Ultrasound
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
      • Surgical Sealants
Deal Status
  • Final
Deal Type
  • Acquisition
    • Payment Includes Cash
    • Full Acquisition
    • Includes Contract
    • Payment Includes Stock

Related Companies

Advertisement
UsernamePublicRestriction

Register